Literature DB >> 25847613

Rocuronium and sugammadex under TOF monitoring on mECT.

Shinsuke Hamaguchi1, Nobuko Tezuka2, Masaru Nagao2.   

Abstract

Entities:  

Keywords:  Rocuronium; Sugammadex; TOF; mECT

Mesh：

Substances：

Year:  2015        PMID： 25847613     DOI： 10.1007/s00540-015-2009-9

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  3 in total

1.  Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy.

Authors:  Hiroko Hoshi; Yuji Kadoi; Jiro Kamiyama; Akiko Nishida; Hiroyuki Saito; Masaki Taguchi; Shigeru Saito
Journal:  J Anesth       Date:  2011-02-04       Impact factor: 2.078

2.  Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.

Authors:  J B Valdrighi; N W Fleming; B K Smith; G L Baker; D A White
Journal:  Br J Anaesth       Date:  1994-02       Impact factor: 9.166

3.  Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium.

Authors:  Shiroh Isono; Kei Iizuka; Goro Fukami; Norihiro Shinozuka; Masaomi Iyo; Takashi Nishino
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.